WASHINGTON — The ERISA Industry Committee (ERIC) issued the following statement following the Supreme Court’s unanimous decision today in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., upholding the viability of skinny labels for generic drug manufacturers.
Topic Archives:
ERISA Preemption Victory: ERIC Applauds Sixth Circuit Ruling Upholding ERISA Employer Plan Protections
WASHINGTON, D.C., April 8, 2026 –The U.S. Court of Appeals for the Sixth Circuit yesterday affirmed the decision of the lower court in McKee Foods Corporation v. BFP, Inc. The court agreed with McKee Foods that the Employee Retirement Income Security Act (ERISA) preempts key provisions of Tennessee’s law requiring that employers include “any willing pharmacy” in the networks maintained by the pharmacy benefit plans that employers sponsor for workers and their families, among other provisions.
ERIC On Weyerhaeuser Pension Risk Transfer Case: A “Meaningful Outcome”
WASHINGTON, D.C., April 2, 2026 – On Thursday, April 2, The ERISA Industry Committee (ERIC) applauded this week’s dismissal of Maneman v. Weyerhaeuser Company by the U.S. District Court for the Western District of Washington. The case represents a growing trend of class action litigation targeting pension plan transactions.
ERIC Victory: Congress Passes PBM & Hospital Billing Reforms
This week, Congress did something that doesn’t happen often enough in Washington, DC – it proved the political pundits wrong. It passed a bill that included a host of health policy reforms championed by Republicans, Democrats, and Independents for the last 8 years. Importantly, these reforms reflect the policies ERIC has long fought for, including …
Continue reading “ERIC Victory: Congress Passes PBM & Hospital Billing Reforms”
ERIC Applauds Final Passage of Health Policies that Will Improve Affordability for Employers and Working Families
Washington, D.C. February 3, 2026– The ERISA Industry Committee (ERIC) today praised passage of the Consolidated Appropriations Act of 2026 (the CAA) as a victory for the more than 160 million workers and families who receive their coverage through the employer-based system.
The Hill Names ERIC’s James Gelfand as a 2025 Top Lobbyist
Washington, D.C., December 11, 2025 – The ERISA Industry Committee (ERIC) today announced that its President and CEO, James Gelfand, has been named one of The Hill’s Top Lobbyists.
ERIC President and CEO James Gelfand Named a Top Lobbyist of 2025
Washington, D.C., October 23, 2025– Today, The ERISA Industry Committee (ERIC) announced that its President and CEO, James Gelfand, has been named one of the Top 100 Lobbyists in the U.S. by the National Institute for Lobbying & Ethics (NILE), an organization representing lobbying, public policy, and government affairs professionals. Gelfand and the other 2025 recipients will be honored on November 3rd during a reception in Washington, D.C.
Employers Recognize Improvements to California PBM Legislation Recently Signed Into Law – Will Monitor Regulatory Process to Ensure Proper Implementation
Washington, D.C., October 15, 2025– Dillon Clair, Director of State Advocacy for The ERISA Industry Committee (ERIC), issued the statement below following Governor Newsom’s signing of Senate Bill 41 to reform the practices of Pharmacy Benefit Managers (PBMs) across California. During the legislative process, ERIC worked closely with lawmakers to ensure the bill would not interfere with the design and administration of self-funded health benefit plans governed by the federal Employee Retirement Income Security Act of 1974 (“ERISA”).
ERIC Applauds Dismissal of Bueno v. General Electric
Washington, D.C., September 24, 2025– The ERISA Industry Committee (ERIC) applauded today’s dismissal of Bueno v. General Electric (GE).
PBM Reform Bill Reflects Effort to Balance State Oversight with ERISA Uniformity
Washington, D.C., September 15, 2025– The ERISA Industry Committee expressed appreciation today for efforts taken by the California State Legislature to amend SB 41 and avoid conflict with federally-governed, self-insured ERISA plans. The bill, which aims to address rising prescription drug costs by regulating the network and reimbursement practices of pharmacy benefit managers (PBMs), is now structured to uphold the uniformity and flexibility that employers have to design and administer multi-state plans under the Employee Retirement Income Security Act (“ERISA”). Both the Assembly and the Senate adopted the legislation unanimously after amendments were reconciled, and it has been sent to Governor Newsom (D-CA), who has until October 13 to sign the bill or issue a veto.